ArticleOncotarget2017
Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant
Kerstin Maria Kampa-Schittenhelm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleOncotarget2017
Kerstin Maria Kampa-Schittenhelm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.